Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 3/2006

01-07-2006 | Original Article

Analysis of non-genetic risk factors for adverse skin reactions to radiotherapy among 284 Breast Cancer patients

Authors: Mayumi Iwakawa, Shuhei Noda, Shigeru Yamada, Naohito Yamamoto, Yukimasa Miyazawa, Hideya Yamazaki, Yoshihiro Kawakami, Yoshifumi Matsui, Hirohiko Tsujii, Junetsu Mizoe, Eisei Oda, Yukihiro Fukunaga, Takashi Imai

Published in: Breast Cancer | Issue 3/2006

Login to get access
Metadata
Title
Analysis of non-genetic risk factors for adverse skin reactions to radiotherapy among 284 Breast Cancer patients
Authors
Mayumi Iwakawa
Shuhei Noda
Shigeru Yamada
Naohito Yamamoto
Yukimasa Miyazawa
Hideya Yamazaki
Yoshihiro Kawakami
Yoshifumi Matsui
Hirohiko Tsujii
Junetsu Mizoe
Eisei Oda
Yukihiro Fukunaga
Takashi Imai
Publication date
01-07-2006
Publisher
Springer-Verlag
Published in
Breast Cancer / Issue 3/2006
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.2325/jbcs.13.300

Other articles of this Issue 3/2006

Breast Cancer 3/2006 Go to the issue

Original Article

A pilot study of wider use of accelerated partial Breast irradiation: Intraoperative margin-directed re-excision combined with sole high-dose-rate interstitial brachytherapy

Editorial

Pathological information for Breast Cancer therapy

Original Article

Adjuvant therapy for Breast Cancer in Kyushu

Case Report

Sudden hemorrhage without skin invasion in a patient with Breast Cancer: A case report and literature review

Case Report

Primary Breast mucosa-associated lymphoid tissue (malt) lymphoma with high-grade transformation evidenced by prominent lymphoepithelial lesions

Review Article

Immunohistochemical evaluation for hormone receptors in Breast Cancer: A practically useful evaluation system and handling protocol
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits